Search & Analyze

Artemis Medicare Services Ltd.

HealthcareHospital & Healthcare Services

www.artemishospitals.com BSE: 542919NSE: ARTEMISMED

₹325.60BSE2.22%

16 Sep, 4:01 PM

₹325.60

₹5.16K Cr

45.43

5.75

12.72%

₹333.00

₹306.40

₹361.50

₹202.85

Customise metrics bar

Price Performance

Peer Comparison

Name
APOLLO HOSP. APOLLOHOSP	8,712.95	59.96	1,25,278.85	0.23	610.40	38.41%	7,043.50	20.56%	21.73
MAXHEALTH MAXHEALTH	1,032.60	68.98	1,00,504.02	0.19	322.96	4.87%	2,366.17	16.70%	14.97
MANIPALHOS MANIPALHOS	714.45	105.32	93,977.12	0.00	243.43	-4.18%	3,090.63	38.12%	13.93
FORTIS FORTIS	868.50	62.57	65,568.12	0.12	272.80	2.26%	2,545.03	17.46%	14.07
ASTERDM ASTERDM	740.00	202.67	64,503.76	0.40	29.28	-68.70%	1,310.68	21.60%	16.22
NH NH	1,855.25	46.37	37,914.04	0.24	207.27	5.37%	2,683.63	78.05%	16.20
MEDANTA MEDANTA	1,406.40	67.92	37,814.13	0.04	157.25	-1.09%	1,304.05	26.50%	19.38
Artemis Medicare Services Ltd. ARTEMISMED	325.60	45.43	5,163.16	0.14	31.44	48.33%	287.32	12.69%	15.83

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	223.20	241.42	232.39	239.90	254.96	274.70	272.35	279.23	287.32
Expenses	187.04	199.16	194.93	204.01	213.57	224.08	227.78	227.63	230.88
	36.17	42.26	37.46	35.89	41.40	50.62	44.57	51.59	56.44
	16.20%	17.51%	16.12%	14.96%	16.24%	18.43%	16.36%	18.48%	19.65%
	4.40	7.44	8.80	12.35	6.93	7.65	4.39	7.79	5.37
Interest	8.13	7.98	8.00	7.83	7.38	7.19	6.75	6.37	6.46
	10.80	11.17	11.45	11.74	11.16	11.71	12.44	12.75	12.73
	21.64	30.55	26.81	28.66	29.79	39.38	29.76	40.25	42.63
	23.64%	27.57%	23.17%	20.03%	28.83%	23.81%	25.30%	24.77%	26.24%
	16.67	22.26	20.67	23.03	21.28	29.97	22.34	30.03	31.31
	1.22	1.62	1.50	1.67	1.53	2.16	1.41	1.90	1.98

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME:
Operating Income	554.80	737.43	878.57	936.92	1,081.24
Operating Income (Net)	554.80	737.43	878.57	936.92	1,081.24
EXPENDITURE :
Increase/Decrease in Stock	0.13	-0.00		0.01
Cost of Medicines and Consumables	154.91	191.06	218.66	227.44	253.85
Power & Fuel Cost	13.03	16.05	15.97	16.68	17.54
Employee Cost	104.30	120.78	138.95	148.37	166.07
Hospital Operation Expenses	199.10	288.15	344.85	359.51	421.56
Selling, Administration and Other Expenses	12.74	22.04	22.31	26.03	28.10
Miscellaneous Expenses	4.12	5.40	5.14	7.10	5.94
	488.33	643.48	745.87	785.13	893.07
Operating Profit (Excl OI)	66.47	93.95	132.70	151.79	188.18
	4.88	7.34	7.35	32.99	29.83
	71.35	101.29	140.06	184.78	218.01
Interest	11.98	19.68	31.29	31.94	27.69
PBDT	59.38	81.61	108.77	152.83	190.32
	22.19	31.00	40.32	45.16	48.07
Profit Before Taxation & Exceptional Items	37.18	50.61	68.45	107.67	142.25
Exceptional Income / Expenses					-3.07
	37.18	50.61	68.45	107.67	139.18
Provision for Tax	5.78	12.59	19.31	25.49	35.46
	31.40	38.01	49.14	82.18	103.72
Extra items				0.00	0.00
Minority Interest	0.41	0.59	-0.00	0.45	-0.10
Consolidated Net Profit	31.81	38.60	49.14	82.63	103.62
Profit Balance B/F	96.88	128.69	167.29	210.31	278.01
Appropriations	128.69	167.29	216.43	292.94	381.63
Equity Dividend %		45.00%	45.00%	45.00%	45.00%
	2.40	2.88	3.62	6.00	6.55
Adjusted EPS	2.40	2.88	3.62	6.00	6.55

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	13.24	13.41	13.59	13.76	15.83
Share Warrants & Outstandings	7.75	8.06	6.51	3.72
Total Reserves	338.43	381.67	428.25	820.19	918.88
Reserve excluding Revaluation Reserve	271.50	314.27	360.27	751.70	849.95
Revaluation reserve	66.93	67.41	67.98	68.49	68.93
	359.42	403.15	448.35	837.68	934.71
Minority Interest	1.84	4.54	6.33	5.88	5.97
Secured Loans	161.29	213.59	227.72	209.48	189.95
Deferred Tax Assets / Liabilities	25.72	29.52	35.34	35.76	41.54
Other Long Term Liabilities	14.96	39.37	58.55	39.64	30.92
Long Term Provisions	24.37	34.25	40.94	54.88	64.87
Total Non-Current Liabilities	226.34	316.72	362.54	339.76	327.28
Trade Payables	59.97	88.18	94.52	101.12	98.46
Other Current Liabilities	67.64	106.33	77.54	100.91	92.56
Short Term Provisions	10.54	11.28	12.60	14.10	48.59
Total Current Liabilities	138.16	205.79	184.65	216.13	239.61
Total Liabilities	725.76	930.21	1,001.88	1,399.44	1,507.57
Gross Block	597.68	745.06	885.38	937.72	1,037.10
Less: Accumulated Depreciation	109.15	139.78	166.11	193.02	232.80
Net Block	488.54	605.28	719.27	744.70	804.30
Capital Work in Progress	62.23	94.68	33.45	38.72	27.82
Long Term Investment		0.00	0.00
Long Term Loans & Advances	45.43	58.84	68.36	77.79	216.30
Other Non Current Assets	0.57	1.01	0.71	1.43	62.67
Total Non-Current Assets	598.71	759.85	821.78	864.33	1,111.92
Inventories	12.40	13.99	10.08	9.98	13.42
Sundry Debtors	73.41	93.28	94.82	101.32	119.61
Cash and Bank	27.70	50.94	61.34	395.54	206.14
Other Current Assets	6.55	3.93	4.41	19.11	14.03
Short Term Loans and Advances	6.99	8.22	9.44	9.16	42.44
Total Current Assets	127.05	170.35	180.10	535.11	395.65
Net Current Assets (Including Current Investments)	-11.11	-35.44	-4.55	318.98	156.04
Total Assets	725.76	930.21	1,001.88	1,399.44	1,507.57
Contingent Liabilities	62.78	65.28	86.32	144.57	205.54
Total Debt	183.56	241.54	253.56	245.82	226.86
	21.51	24.43	27.52	55.63	54.69
Adjusted Book Value	21.51	24.43	27.52	55.63	54.69

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	37.18	50.61	68.45	107.67	139.18
Adjustment	38.33	49.25	60.20	51.99	49.75
Changes In working Capital	-32.69	30.18	-4.19	9.90	-40.40
Cash Flow after changes in Working Capital	42.83	130.04	124.45	169.55	148.52
Cash Flow from Operating Activities	59.53	127.16	108.85	155.70	131.95
Cash Flow from Investing Activities	-107.22	-158.21	-88.14	-393.22	-90.03
Cash Flow from Financing Activitie	44.22	38.22	-28.98	264.50	-50.10
Net Cash Inflow / Outflow	-3.46	7.17	-8.26	26.98	-8.18
Opening Cash & Cash Equivalents	19.16	15.70	22.87	14.61	41.59
Closing Cash & Cash Equivalent	15.70	22.87	14.61	41.59	33.40

Ratios

Valuation

45.43

5.75

22.39

4.64

7.18

56.68

Profitability

12.72

15.83

7.14

17.40

9.59

Leverage & Liquidity

0.26

1.65

6.03

Returns

0.14

0.74

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	67.51	67.17	67.17	67.17	66.53	66.53	58.39	58.39	58.39
	10.73	10.91	12.23	12.44	12.02	11.66	21.54	21.24	20.85
	21.76	21.92	20.60	20.39	21.46	21.81	20.08	20.37	20.76
	32.49	32.83	32.83	32.83	33.47	33.47	41.61	41.61	41.61
No. of Shareholders	19,795	26,054	27,004	28,397	31,614	33,559	31,602	32,044	36,335

Corporate Actions

Showing: All

Date	Type	Details
2026-07-29	Board Meeting	Quarterly Results
2026-06-19	AGM
2026-06-01	Board Meeting	Inter alia, to consider and approve the Notice of the Postal Ballot for seeking the approval of Members of the Company for raising of funds for an aggregate amount not exceeding Rs. 700 crores (Rupees Seven Hundred Crores Only), in one or more tranches, through any of the permissible modes, subject to the receipt of necessary approvals. The aforesaid proposal was approved by the Board of Directors of the Company at its meeting held on February 2, 2026, and the disclosure in this regard was submitted to Stock Exchange(s) on the same day.

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareHospital & Healthcare Services

Artemis Medicare Services Ltd. operates in the Healthcare sector under the Hospital & Healthcare Services industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

13 members across the board and senior leadership

Poonam Makkar

Company Secretary & Compliance Officer

—

Onkar Kanwar

Chairman

₹20.00 L

Mar '26

Neeraj Kanwar

Non Executive Director

₹20.60 L

Mar '26

Shalini Kanwar Chand

Non Executive Director

₹21.00 L

Mar '26

Devlina Chakravarty

Managing Director

₹52.69 Cr

Mar '26

Vinod Rai